KLRG1 and relapsing-remitting multiple sclerosis: These results show that NK cells from newly diagnosed patients with RRMS have increased percentages of the inhibitory KLRG1+ within the most immature NK cells subset and increased percentages of the activating NKp30+ within the most mature NK cells subset.